These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22589109)

  • 1. Native analysis of plasma-derived clotting factor VIII concentrates: "sponge effect" and contaminants.
    Blasi B; D'Amici GM; D'Alessandro A; Zolla L
    Electrophoresis; 2012 Apr; 33(8):1292-8. PubMed ID: 22589109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma-derived clotting factor VIII: heterogeneity evaluation in the quest for potential inhibitory-antibody stimulating factors.
    D'Amici GM; Blasi B; D'Alessandro A; Vaglio S; Zolla L
    Electrophoresis; 2011 Nov; 32(21):2941-50. PubMed ID: 21997645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison among plasma-derived clotting factor VIII by using monodimensional gel electrophoresis and mass spectrometry.
    Timperio AM; Gevi F; Grazzini G; Vaglio S; Zolla L
    Blood Transfus; 2010 Jun; 8 Suppl 3(Suppl 3):s98-104. PubMed ID: 20606759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of factor VIII pharmaceutical preparations by means of MudPIT proteomic approach.
    Basilico F; Nardini I; Mori F; Brambilla E; Benazzi L; De Palma A; Rosti E; Farina C; Mauri P
    J Pharm Biomed Anal; 2010 Sep; 53(1):50-7. PubMed ID: 20399057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factor VIII preparations of varying purity-examination of physico-chemical parameters (author's transl)].
    Vukovich T; Koller E; Doleschel W; Mayr WR
    Wien Klin Wochenschr; 1980; 92(11):385-91. PubMed ID: 6775418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VIII heavy chain polypeptides in plasma and concentrates.
    Kemball-Cook G; Bevan SA; Barrowcliffe TW
    Br J Haematol; 1990 Sep; 76(1):80-7. PubMed ID: 2121265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant clotting factor VIII concentrates: Heterogeneity and high-purity evaluation.
    D'Amici GM; Timperio AM; Gevi F; Grazzini G; Zolla L
    Electrophoresis; 2010 Aug; 31(16):2730-9. PubMed ID: 20737444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization of various factor VIII concentrates.
    Yoshioka A; Shima M; Nishino M; Yoshikawa N; Fukui H
    Arzneimittelforschung; 1987 Jul; 37(7):753-6. PubMed ID: 3118888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-dimensional blue native/blue native polyacrylamide gel electrophoresis for the characterization of mitochondrial protein complexes and supercomplexes.
    Sunderhaus S; Eubel H; Braun HP
    Methods Mol Biol; 2007; 372():315-24. PubMed ID: 18314736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII test in reference preparations: compensation for different dilutions.
    König H; Rosenkranz S; Nawrot R; Hunfeld A; Seitz R
    Pharmeur Sci Notes; 2005 Aug; 2005(1):11-3. PubMed ID: 17687888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic study of muscle sarcoplasmic proteins using AUT-PAGE/SDS-PAGE as two-dimensional gel electrophoresis.
    Picariello G; De Martino A; Mamone G; Ferranti P; Addeo F; Faccia M; Spagnamusso S; Di Luccia A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):101-8. PubMed ID: 16503425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The factor VIII/von Willebrand factor complex: basic and clinical issues.
    Federici AB
    Haematologica; 2003 Jun; 88(6):EREP02. PubMed ID: 12826528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of plasma-derived factor VIII/von Willebrand factor concentrates in the treatment of hemophilia A patients.
    Auerswald G; Spranger T; Brackmann HH
    Haematologica; 2003 Jun; 88(6):EREP05. PubMed ID: 12826531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human parvovirus PARV4 in clotting factor VIII concentrates.
    Fryer JF; Hubbard AR; Baylis SA
    Vox Sang; 2007 Nov; 93(4):341-7. PubMed ID: 18070279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The simplified technique of high resolution two-dimensional polyacrylamide gel electrophoresis: biomedical applications in health and disease.
    Marshall T; Williams KM
    Electrophoresis; 1991; 12(7-8):461-71. PubMed ID: 1915239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A solvent/detergent-treated and 15-nm filtered factor VIII: a new safety standard for plasma-derived coagulation factor concentrates.
    Chtourou S; Porte P; Nogré M; Bihoreau N; Cheesman E; Samor B; Sauger A; Raut S; Mazurier C
    Vox Sang; 2007 May; 92(4):327-37. PubMed ID: 17456157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates.
    Budde U; Drewke E
    Beitr Infusionsther Transfusionsmed; 1994; 32():408-14. PubMed ID: 9422121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent molecular weight of purified human factor VIII procoagulant protein compared with purified and plasma factor VIII procoagulant protein antigen.
    Weinstein MJ; Fulcher CA; Chute LE; Zimmerman TS
    Blood; 1983 Nov; 62(5):1114-7. PubMed ID: 6414554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.